• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

@rachel

Profile

Registered: 13 years ago


Forums

Topics Started: 2

Replies Created: 0

Forum Role: Keymaster

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • John Dinon, Australia

    John Dinon, Australia

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • David Solomon, UK

    David Solomon, UK

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Timmy, Belgium

    Timmy, Belgium

  • Denis Blais, Canada

    Denis Blais, Canada

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Sally Pauls, USA

    Sally Pauls, USA

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Paul Launer, USA

    Paul Launer, USA

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Bob Simonds, USA

    Bob Simonds, USA

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Lombana, Spain

    Lombana, Spain

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • David Bishop, UK

    David Bishop, UK

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Jean Waters, UK

    Jean Waters, UK

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Rosie Riley, USA

    Rosie Riley, USA

  • Frank Taylor, USA

    Frank Taylor, USA

  • Sébastien Batiot, France

    Sébastien Batiot, France

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login